Vancouver, British Columbia and Rehovot, Israel – July 18, 2022 – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) ”)  is pleased to announce that its common shares are now trading on the OTCQB® Venture Market under the ticker symbol “CNVCF”.

“Admission to the OTCQB® market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of transparency as we expand both our investor base and our customer base in North America.” Stated CEO Ilan Sobel. “We will continue to work on expanding our global visibility to investors to match the commercial entry of our products into new markets.”

The BioHarvest Sciences Executive team holds regular online meetings to maintain close ties with the US investment community. All interested media and investors are invited to contact info@bioharvest.com for information on the Company’s next interactive event. For more detail on 2022 progress, the July 7, Q2 Shareholder Update focuses on the Company’s scale-up plans in the US for its VINIA product, and the market entry strategy for the Company’s cannabis products. The recording of that event is available here: https://bioharvest.com/investors/

About the OTCQB Market

The OTCQB® Venture Market is for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their financial reporting and undergo an annual verification and management certification process. The OTCQB® quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.

Investors can find current financial disclosure and quotes for the company on https://www.otcmarkets.com/stock/CNVCF.

BioHarvest Sciences will continue to trade on the Canadian Securities Exchange (CSE) as “BHSC” and on Frankfurt as “8MV”.

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technologyis economical, ensures consistency, and avoids the negative environmental impacts associated with traditionalagriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets. Visit: www.bioharvest.com.